OS Therapies Statistics

Total Valuation

OS Therapies has a market cap or net worth of $53.77 million. The enterprise value is $53.50 million.

Market Cap	53.77M
Enterprise Value	53.50M

Important Dates

The next estimated earnings date is Friday, May 15, 2026, before market open.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

OS Therapies has 39.53 million shares outstanding. The number of shares has increased by 321.31% in one year.

Current Share Class	39.53M
Shares Outstanding	39.53M
Shares Change (YoY)	+321.31%
Shares Change (QoQ)	+9.03%
Owned by Insiders (%)	13.99%
Owned by Institutions (%)	4.53%
Float	31.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio	0.03
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-289.88%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	582.87%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$5.75M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.26%
50-Day Moving Average	1.40
200-Day Moving Average	1.74
Relative Strength Index (RSI)	44.65
Average Volume (20 Days)	560,032

Short Selling Information

The latest short interest is 1.29 million, so 3.27% of the outstanding shares have been sold short.

Short Interest	1.29M
Short Previous Month	1.37M
Short % of Shares Out	3.27%
Short % of Float	4.15%
Short Ratio (days to cover)	3.46

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-28.71M
Pretax Income	-28.75M
Net Income	-28.75M
EBITDA	-28.34M
EBIT	-28.71M
Earnings Per Share (EPS)	-$0.98

Full Income Statement

Balance Sheet

The company has $269,830 in cash and n/a in debt, with a net cash position of $269,830 or $0.01 per share.

Cash & Cash Equivalents	269,830
Total Debt	n/a
Net Cash	269,830
Net Cash Per Share	$0.01
Equity (Book Value)	-5.02M
Book Value Per Share	-0.16
Working Capital	-11.43M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-14.24M
Capital Expenditures	n/a
Depreciation & Amortization	363,085
Net Borrowing	n/a
Free Cash Flow	-14.24M
FCF Per Share	-$0.36

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OS Therapies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-321.31%
Shareholder Yield	-321.31%
Earnings Yield	-53.48%
FCF Yield	-26.48%

Analyst Forecast

The average price target for OS Therapies is $18.50, which is 1,260.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.50
Price Target Difference	1,260.29%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1